EnteroMedics' Series B Round

EnteroMedics raised a round of funding on December 14, 2005.

EnteroMedics (NASDAQ: ETRM) has developed vBloc® vagal blocking therapy, a unique, broadly patented therapeutic approach to treat a range of gastrointestinal and metabolic diseases. vBloc® is a firs…

Articles about EnteroMedics' Series B Round: